Prostate cancer decisions — 2024

The Veteran's service connection claims for type 2 diabetes and prostate cancer are granted due to presumed exposure to herbicide agents during his service in Korea. However, the claims for bilateral upper and lower extremity diabetic neuropathy are denied as there is no current diagnosis of these conditions.

The Veteran's claim for service connection for erectile dysfunction as secondary to prostatitis was granted with an effective date of October 4, 2005. The decision is based on new and material evidence submitted after the initial denial in December 2006.

The Veteran's cause of death was due to lung, kidney, and prostate cancers, which are presumptively related to his service. The appeal for service connection for cause of death is granted.

The Veteran's prostate cancer is rated at 100% and he receives special monthly compensation, making it impossible for him to secure or follow a substantially gainful occupation. Therefore, the claim for Dependents' Educational Assistance (DEA) benefits pursuant to 38 U.S.C. chapter 35 is denied.

The Board denied the Veteran's claim for a TDIU for the period prior to June 21, 2023, finding that his service-connected disabilities did not preclude him from securing and following a substantially gainful occupation. The Board dismissed the TDIU claim for the period from June 21, 2023, as moot due to the Veteran's receipt of a 100% combined disability rating.

The Board has decided to remand the case due to a lack of a medical opinion regarding the relationship between the Veteran's service-connected exposure to asbestos and his cause of death from metastatic prostate cancer. The claim will be reconsidered with the submission of a VA opinion.

The Board denied the Veteran's claim for service connection for prostate cancer as new and relevant evidence was not received with his July 2020 supplemental claim.

The Veteran's prostate cancer is presumed to be related to his service in or near the Korean DMZ, and the Board has granted service connection for this condition.

The Board has remanded the claims for prostate cancer and type 2 diabetes mellitus due to a duty to assist error, specifically failing to provide VA examinations or opinions regarding the nature and likely etiology of the Veteran's claimed conditions. The claims are being returned to the AOJ for further development.

The Veteran's prostate cancer is granted service connection, while the lung disability claim remains pending and remanded for further examination.

The Board denied an initial disability rating in excess of 60 percent for prostate cancer residuals and a compensable rating for bilateral hearing loss, but vacated the portion of the decision regarding prostate cancer due to procedural issues.

Service connection for dementia, secondary to PTSD, is granted.,The Veteran's claim of service connection for prostate cancer has been reopened.

The Veteran's prostate cancer is granted as service-connected on a direct basis due to in-service herbicide exposure at U-Tapao Air Force Base.

The Board has denied service connection for benign prostatic hyperplasia (BPH) as the evidence does not support a finding that it was incurred in service or related to herbicide exposure. Service connection for prostate cancer, however, was granted.

Your appeal for service connection for prostate cancer has been dismissed because the issue was resolved in your favor and no longer needs to be reviewed.

The Veteran's prostate cancer is granted service connection as it falls under the presumptive conditions for exposure to herbicide agents, specifically Gulf War Syndrome.

The Veteran's combined service-connected rating is 90 percent, which does not meet the criteria for a 100 percent rating.

The Board has found new and relevant evidence to remand the claims for service connection for Parkinson's disease, prostate cancer, and throat cancer due to potential exposure to toxins. The Veteran is required to undergo VA examinations to determine if these conditions are related to his military service.

The Veteran's appeal for a higher rating for bladder cancer residuals, which included voiding dysfunction, was denied. The proposed reduction in the prostate cancer rating from 100% to 40% was dismissed as it is not yet ripe for review.

The Veteran's metastatic prostate cancer is granted as service connected due to exposure to herbicide agents in Guam, and the Board finds that the evidence supports this decision.